SCHEMBL30976508

SCHEMBL30976508

Cn1nc(C(=O)O)c2cc(F)ccc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.49
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
LMNA P02545 3/20 0.44
POLB P06746 4/20 0.44
ALDH1A1 P00352 4/20 0.44
PKM P14618 2/20 0.44
TSHR P16473 2/20 0.44
HTT P42858 2/20 0.44
NR2F2 P24468 1/20 0.44
KDM4E B2RXH2 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
APAF1 O14727 1/20 0.43
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
HPGD P15428 1/20 0.43
GAA P10253 1/20 0.42
USP2 O75604 1/20 0.41
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30976257 0.82 ALDH1A1 (0.44) KMT2AMEN1LMNAPOLBALDH1A1
SCHEMBL15025470 0.81 KDM4C (0.49) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL29805505 0.81 KDM4C (0.49) SMN1; SMN2KMT2AMEN1ALDH1A1KDM4E
SCHEMBL8157443 0.79 KDM4E (0.39) SMN1; SMN2KMT2AMEN1LMNAALDH1A1
SCHEMBL3652058 0.79 ALDH1A1 (0.64) SMN1; SMN2KMT2AMEN1LMNAPOLB
SCHEMBL30976438 0.77 MEN1 (0.57) SMN1; SMN2KMT2AMEN1LMNAPOLB
SCHEMBL30976239 0.76 TSHR (0.45) SMN1; SMN2LMNAPOLBALDH1A1PKM
SCHEMBL30976241 0.74 MEN1 (0.50) SMN1; SMN2KMT2AMEN1LMNAPOLB
SCHEMBL30976297 0.73 PARG (0.50) SMN1; SMN2POLBTSHRHTTNR2F2
SCHEMBL30976254 0.73 KDM4E (0.43) SMN1; SMN2LMNAPOLBALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619387-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2025-09-24 EP disclosed
WO-2024108131-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-05-23 WO disclosed